ask="N/A"
ask_size="N/A"
average_daily_volume="909490"
bid="5.71"
bid_size="1000"
book_value="0.05"
change="-0.08"
change_from_200_day_moving_average="0.62"
change_from_50_day_moving_average="-0.41"
change_from_52_week_high="-1.78"
change_From_52_week_low="4.15"
change_in_percent="-1.37%"
close="5.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42554000"
high="5.89"
high_52_weeks="7.56"
last_trade_date="2/14/2017"
last_trade_price="5.78"
last_trade_size="37633"
last_trade_time="4:00pm"
low="5.60"
low_52_weeks="1.63"
market_capitalization="426.32M"
moving_average_200_day="5.16"
moving_average_50_day="6.19"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.50"
open="5.84"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+12.09%"
percent_change_from_50_day_moving_average="-6.61%"
percent_change_from_52_week_high="-23.54%"
percent_change_from_52_week_low="+254.60%"
previous_close="5.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="108.52"
price_per_sales="19.67"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="817094"
weeks_range_52="1.63 - 7.56"
